The cells of this breast carcinoma are highly positive for estrogen receptor (ER) with this immunohistochemical stain. ER positivity in a breast carcinoma correlates with a better prognosis because such ER positive neoplastic cells are better differentiated and more amenable to hormonal manipulation with chemical agents such as tamoxifen.